Successful repeated treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP
2009 (English)In: BMJ case reports, ISSN 1757-790XArticle in journal (Refereed) Published
Chronic inflammatory demyelinating polyneuropathy (CIDP) is characterised by the occurrence of symmetrical weakness and sensory impairment in arms and legs. The course is relapsing or chronic and progressing. CIDP is considered to be an autoimmune disease, which is supported by the beneficial response to immunomodulating therapies in most patients. We report on a patient with CIDP who has been in remission for more than 3 years after treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP on two occasions.
Place, publisher, year, edition, pages
Neurology Clinical Laboratory Medicine Hematology
IdentifiersURN: urn:nbn:se:uu:diva-224117DOI: 10.1136/bcr.09.2008.0927PubMedID: 21686555OAI: oai:DiVA.org:uu-224117DiVA: diva2:715338